Skip to main content
Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.81
-0.44 (-3.32%)
At close: Apr 28, 2026, 4:00 PM EDT
13.06
+0.25 (1.95%)
After-hours: Apr 28, 2026, 5:48 PM EDT

Cullinan Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
109
Market Cap
775.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 202118.94M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ARS Pharmaceuticals 84.28M
Kura Oncology 67.48M
Arbutus Biopharma 14.08M
Crescent Biopharma 10.84M
Absci 2.80M
Allogene Therapeutics 22.00K
Revenue Rankings

CGEM News

More News